180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.3

EPS: As of FY2025 Q2, the actual value is USD -0.3.

EBIT: As of FY2025 Q2, the actual value is USD -1.727 M.

Segment Revenue

• Total Operating Expenses: $4,103,383 for the six months ended June 30, 2025, compared to $3,939,206 for the same period in 2024, representing an increase of $164,177 or 4%.

Operational Metrics

• Net Loss: $4,095,836 for the six months ended June 30, 2025, compared to $1,057,963 for the same period in 2024, representing an increase in net loss of $3,037,873 or 287%.
• Research and Development Expenses: $423,291 for the six months ended June 30, 2025, compared to $484,047 for the same period in 2024, representing a decrease of $60,756 or 13%.
• General and Administrative Expenses: $3,404,265 for the six months ended June 30, 2025, compared to $3,150,952 for the same period in 2024, representing an increase of $253,313 or 8%.

Cash Flow

• Net Cash Used In Operating Activities: $1,984,787 for the six months ended June 30, 2025, compared to $306,247 for the same period in 2024.
• Net Cash Used In Financing Activities: $353,320 for the six months ended June 30, 2025, compared to $529,302 for the same period in 2024.

Future Outlook and Strategy

• Core Business Focus: The company plans to strategically enter the online gaming industry, utilizing a blockchain-based business model aimed at the global iGaming market. This includes focusing initially on B2C online casinos and expanding into a B2B model.
• Non-Core Business: The company is evaluating strategic options for its TNF and CBD programs, including potential sale or disposition, return of these assets to the underlying owners, or other strategic alternatives.
• Priority: The company expects to invest a significant amount of capital to commercialize its iGaming assets and fund research and development, with a focus on achieving profitability.